These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Depot medroxyprogesterone acetate: implications for weight status and bone mineral density in the adolescent female. Bonny AE; Harkness LS; Cromer BA Adolesc Med Clin; 2005 Oct; 16(3):569-84. PubMed ID: 16183540 [TBL] [Abstract][Full Text] [Related]
26. [Acceptability of medroxyprogesterone acetate in rural areas of Mexico]. Velasco Murillo V; Cervantes Bustamante A; Correu Azcona S; García López E Ginecol Obstet Mex; 1981 Mar; 49(293):153-61. PubMed ID: 6459270 [TBL] [Abstract][Full Text] [Related]
27. Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women. Ratchanon S; Taneepanichskul S Obstet Gynecol; 2000 Dec; 96(6):926-8. PubMed ID: 11084179 [TBL] [Abstract][Full Text] [Related]
28. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling. Shaarawy M; El-Mallah SY; Seoudi S; Hassan M; Mohsen IA Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229 [TBL] [Abstract][Full Text] [Related]
29. Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine. Cromer BA; Scholes D; Berenson A; Cundy T; Clark MK; Kaunitz AM; J Adolesc Health; 2006 Aug; 39(2):296-301. PubMed ID: 16857545 [TBL] [Abstract][Full Text] [Related]
30. Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'. Lanza LL; McQuay LJ; Rothman KJ; Bone HG; Kaunitz AM; Harel Z; Ataher Q; Ross D; Arena PL; Wolter KD J Fam Plann Reprod Health Care; 2013 Oct; 39(4):306. PubMed ID: 24062508 [No Abstract] [Full Text] [Related]
31. [20 questions aporopos of trimestrial injection of depot contraceptives]. Revaz C Rev Med Suisse Romande; 1975 Sep; 95(9):661-71. PubMed ID: 1215719 [TBL] [Abstract][Full Text] [Related]
32. ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice Obstet Gynecol; 2008 Sep; 112(3):727-30. PubMed ID: 18757687 [No Abstract] [Full Text] [Related]
34. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis]. Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083 [TBL] [Abstract][Full Text] [Related]
35. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? Thurman AR; Hammond N; Brown HE; Roddy ME J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388 [TBL] [Abstract][Full Text] [Related]
36. Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant: making decisions in the absence of evidence. Holman R; Stephen G J Fam Plann Reprod Health Care; 2005 Oct; 31(4):333-4. PubMed ID: 16274569 [No Abstract] [Full Text] [Related]
37. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Clark MK; Sowers MR; Nichols S; Levy B Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863 [TBL] [Abstract][Full Text] [Related]